Our vision is to significantly advance the treatment of patients with neurological or psychiatric disorders by leveraging the latest research within neuromodulation.

The technology developed by Cenexum has the potential to dramatically change the treatment options and open up neurostimulation to a much wider patient group than today.

Our products will build on the unique features of the Cenexum technology enabling a system that locally records data from the area of interest, processes the data leveraging AI and ML, allowing fully closed loop and personalized adjustment of the neurostimulation.

Using miniatured implantable device with wireless power will potentially allow a smoother surgical procedure and less risk of complications like bleedings and infections as no batteries need to be implanted.

The miniatured devices can be connected in a network that will allow the integration of data from several parts of the central and peripheral nervous system to  improve the precision and efficacy of the treatment.

Cenexum’s technology may treat illnesses such as chronic pain, depression, movement disorders, Parkinson’s disease, Alzheimer’s disease, epilepsy, and multisymptomatic mental disorders as alternative to pharmaceuticals and non-reversible surgery.